bpc 157 safety human clinical trial Wolverine Stack: Healing Faster with Peptides Multifunctionality and Possible Medical Application

2023 Ludvik B, Giorgino F, Jodar E et al (2021) Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial

10.1038/s41591-024-02979-8 [DOI] [PMC free article] [PubMed] [Google Scholar] Figueiredo M

Garcia may prescribe Tessamorelin or Ipamorelin or CJC-1295 combined with Ipamorelin to stimulate optimized growth hormone release and visceral fat and metabolic health benefits

Front Physiol 2019;10:914

It is not a magic switch that fixes everything overnight

A 2021 review reported no toxicity in BPC-157 animal studies, with the LD1 not achieved, and noted prior use in ulcerative colitis and multiple sclerosis trials